framycetin has been researched along with Disease Models, Animal in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (23.08) | 18.7374 |
1990's | 17 (21.79) | 18.2507 |
2000's | 16 (20.51) | 29.6817 |
2010's | 24 (30.77) | 24.3611 |
2020's | 3 (3.85) | 2.80 |
Authors | Studies |
---|---|
Bottero, V; Chandran, B; Dutta, S; Johnson, KE; Sadagopan, S; Veettil, MV | 1 |
Chen, J; Chopp, M; Lu, M; Ning, R; Roberts, C; Yan, T; Zacharek, A; Zhang, C | 1 |
Carvalho, I; Corrado, AP; Prado, WA; Rossaneis, AC; Zamoner, LO | 1 |
Ai, C; Jiang, G; Jing, N; Liu, Z; Wang, L; Zhuang, H | 1 |
Akhtar, S; Cosgrove, C; Dellacecca, ER; Engelhard, VH; Knight, KL; Le Poole, IC; Mukhatayev, Z; Rademaker, AW | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Bittinger, K; Bushman, FD; Facciabene, A; Ganetsky, A; Gill, S; Guedan, S; June, CH; Morgan, MA; Pierini, S; Rafail, S; Tanes, C; Tanyi, JL; Uribe-Herranz, M | 1 |
Ajami, NJ; Auchtung, TA; Banerjee, S; Berger, FG; Carson, JA; Chakraborty, P; Chanda, A; Chatzistamou, I; Chumanevich, A; Debnath, I; Depaep, S; Fayad, R; Gummadidala, PM; Kaur, K; O'Brien, JL; Omebeyinje, MH; Petrosino, JF; Saxena, A; Sougiannis, AJ | 1 |
Deepthi, S; Jose, J | 1 |
Benetti, F; Briso, ALF; Cintra, LTÂ; Ervolino, E; Gallinari, MO; Rahal, V | 1 |
Haaning, AM; Quinn, ME; Ware, SM | 1 |
Fallon, JB; Irving, S; Millard, RE; Shepherd, RK; Trotter, MI; Wise, AK | 1 |
Cai, C; Chai, R; He, Y; Li, H; Sun, S; Yu, H | 1 |
Arruebo, MP; Gonzalo, S; Grasa, L; Martínez de Salinas, F; Murillo, MD; Plaza, MÁ; Valero, MS; Vergara, C | 1 |
Gui, QF; Lu, HF; Xu, ZR; Yang, YH; Zhang, CX | 1 |
Illing, RB; Jakob, TF; Rosskothen-Kuhl, N | 1 |
Chae, SW; Chang, J; Choi, J; Im, GJ; Jung, HH; Kwon, SY; Lee, SH; Oh, KH; Park, HC; Rah, YC; Yoo, MH | 1 |
Fransson, A; Ulfendahl, M | 1 |
Arakawa, T; Fujiwara, Y; Gi, M; Nagami, Y; Sawada, A; Shiba, M; Tanaka, F; Tanigawa, T; Tominaga, K; Wanibuchi, H; Watanabe, T; Yamagami, H | 1 |
Bonham, BH; Hradek, GT; Leake, PA; Snyder, RL | 1 |
Hradek, GT; Leake, PA; Snyder, RL; Stakhovskaya, O | 1 |
Amir, A; Brandeis, R; Buch, H; Cohen, L; Cohen, M; Dachir, S; Fishbine, E; Gutman, H; Horwitz, V; Kadar, T; Sahar, R; Solomon, A; Turetz, J | 1 |
Chandra, P; Gewirtz, AT; Hao, L; Jones, DP; Tian, J; Willams, IR; Ziegler, TR | 1 |
Cediel, R; Contreras, J; Murillo-Cuesta, S; Varela-Nieto, I | 1 |
Baker, CA; Chang, LY; Coco, A; Fallon, JB; Montey, KL; Ryugo, DK; Shepherd, RK | 1 |
Galeotti, N; Ghelardini, C | 1 |
Fabris, L; Fiorotto, R; Hoque, R; Scirpo, R; Spirli, C; Strazzabosco, M; Trauner, M | 1 |
Menon, S; Pednekar, S; Shailajan, S; Singh, A | 1 |
Andersson, E; Andrade, N; Brunak, S; Fjord-Larsen, L; Fransson, A; Houchins, JP; Johansen, TE; Jørgensen, JR; Kalkkinen, N; Lindvall, O; Thompson, LH; Torp, M; Ulfendahl, M; Wahlberg, LU | 1 |
Polat, ZA; Vural, A | 1 |
Guo, WW; He, DZ; Hou, ZH; Huang, DL; Sun, JH; Xu, JC; Yang, SM; Young, WY; Yu, N; Zhao, LD | 1 |
Carceller, F; Cuevas, B; Cuevas, P; Diaz-González, D; Dujovny, M; Fernández, A; Garcia-Gómez, I | 1 |
Abereoje, OA; Abudu, A; Agbani, EO; Awe, T; Fakoya, FA; Orafidiya, LO | 1 |
Keshavan, V; Shanthi, M; Tyagi, MG; Vikram, GS | 1 |
Bedja, D; Gabrielson, K; Germino, GG; Grinberg, A; Huso, DL; Liu, L; Mei, C; Piontek, KB; Qian, F; Westphal, H; Zhao, H | 1 |
Carceller, F; Cuevas, P; Dujovny, M; García-Trapero, J | 1 |
Abbas, PJ; Jeng, FC; Miller, CA; Nourski, KV; Robinson, BK | 1 |
Egashira, Y; Kawano, N; Sanada, H | 1 |
Bergheim, I; Bischoff, SC; Kaserouni, S; Krämer, S; McClain, CJ; Volynets, V; Vos, M; Weber, S | 1 |
Batts, SA; Izumikawa, M; Miyazawa, T; Raphael, Y; Swiderski, DL | 1 |
Butler, EJ; Curtis, MJ; Pearson, AW | 1 |
Leake-Jones, PA; Merzenich, MM; O'Reilly, BF; Vivion, MC | 1 |
Kupferman, A; Leibowitz, HM | 3 |
Hartmann, R; Klinke, R; Pfennigdorff, T | 1 |
Apperloo-Renkema, HZ; Dijkstra, HM; Klasen, HJ; Manson, WL; van der Waaij, D | 1 |
Conjeevaram, HS; Kaminsky-Russ, K; Katz, A; McCullough, AJ; Mullen, KD; Nagle, A | 1 |
Beck, DE; Karulf, RE | 1 |
Altschuler, RA; Helfert, RH; Lesperance, MM | 1 |
McElveen, JT; Molter, DW; Saunders, JE | 1 |
Gladstone, HB; Hradek, GT; Schindler, RA; Scott, N; Shah, SB; Williams, H | 1 |
Gladstone, HB; Hradek, GT; Schindler, RA; Shah, SB; Williams, H | 1 |
Blaauw, B; de Smet, B; Dijkstra, HM; Klasen, HJ; Manson, WL | 1 |
Chambers, PL; Kuntz, AL; Leake, PA; Moore, CM | 1 |
Marakusha, BI; Tartakovskił, IS; Temezhnikova, ND | 1 |
Federoff, H; Gabaizadeh, R; Staecker, H; Van De Water, TR | 1 |
Alper, CM; Bluestone, CD; Casselbrant, ML; Dohar, JE; Doyle, WJ; Kenna, MA; Rose, EA | 1 |
Arndt, H; Palitzsch, KD; Schölmerich, J | 1 |
Brenner, DA; Enomoto, A; Enomoto, N; Kono, H; Nishimura, T; Nishiura, T; Rivera, CA; Schemmer, P; Thurman, RG; Yamashina, S | 1 |
Certoux, JM; Chalmers, D; Contassot, E; Ferrand, C; Hervé, P; Maddens, S; Otto, E; Tiberghien, P | 1 |
Büssow, H; Spörkel, O; Stoffel, W; Uschkureit, T | 1 |
Machado Filho, EB; Prado, WA | 1 |
Boucher, RC; Brigman, K; Kim, HS; Koller, BH; Latour, AM; Scambler, P; Smithies, O; Wainwright, B | 1 |
Morizono, T | 1 |
Altschuler, RA; Zappia, JJ | 1 |
Carman, MD; Gamba-Vitalo, C; Sartorelli, AC | 1 |
Köhler, B; Mochmann, H; Richter, U | 1 |
Lindner, A; Rudas, B; Selzer, H | 1 |
Chandler, JW; Gasset, A; Sugar, J | 1 |
Chandler, JW; Sugar, J | 1 |
Barlow, B; Blanc, WA; Heird, WC; Pitt, J; Santulli, TV; Schullinger, JN | 1 |
Clark, WW; Pearson, RD; Stebbins, WC; Weiland, NG | 1 |
Bonardi, G; Coppi, G | 1 |
Gláz, ET | 1 |
Chamberlain, RE; Das, NK | 1 |
Linevich, IuG; Otman, LS; Zueva, VS | 1 |
Biró, L; Iván, E | 1 |
1 review(s) available for framycetin and Disease Models, Animal
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
1 trial(s) available for framycetin and Disease Models, Animal
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
77 other study(ies) available for framycetin and Disease Models, Animal
Article | Year |
---|---|
Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.
Topics: Animals; Antineoplastic Agents; Ascites; Body Weight; Cell Line, Tumor; Disease Models, Animal; Framycetin; Herpesvirus 8, Human; Lymphoma, Primary Effusion; Mice; Mice, SCID; Neomycin; Ribonuclease, Pancreatic; Spleen; Survival Analysis; Treatment Outcome | 2013 |
Neamine induces neuroprotection after acute ischemic stroke in type one diabetic rats.
Topics: Angiopoietins; Animals; Blood Pressure; Blood-Brain Barrier; Body Temperature; Caspase 3; Diabetes Mellitus, Experimental; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Framycetin; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Time Factors; Toll-Like Receptor 4 | 2014 |
Neamine and 2-deoxystreptamine neomycin derivatives exhibit antinociceptive activity in rat models of phasic, incision and neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Framycetin; Hexosamines; Injections, Spinal; Male; Molecular Structure; Neuralgia; Nociception; Nociceptive Pain; Pain Measurement; Pain Threshold; Pain, Postoperative; Rats, Wistar; Reaction Time; Structure-Activity Relationship; Time Factors | 2015 |
Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer.
Topics: Animals; Anti-Bacterial Agents; Colitis; Colon; Colonic Neoplasms; Cytokines; Disease Models, Animal; Female; Immunity; Male; Metronidazole; Mice; Neomycin | 2022 |
Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice.
Topics: Administration, Oral; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides; Cytokines; Disease Models, Animal; DNA, Bacterial; Dysbiosis; Feces; Female; Humans; Intestinal Mucosa; Male; Mice; Microbiota; Neomycin; Pseudomonas; RNA, Ribosomal, 16S; Skin; T-Lymphocytes, Regulatory; Vitiligo | 2020 |
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.
Topics: Adult; Aged; Animals; Bacteria; CD8 Antigens; Cell Line, Tumor; Cohort Studies; Dendritic Cells; Disease Models, Animal; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Hematopoietic Stem Cell Transplantation; Host Microbial Interactions; Humans; Immunotherapy, Adoptive; Interleukin-12; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neomycin; Neoplasms; T-Lymphocytes; Treatment Outcome; Vancomycin | 2018 |
Antibiotic-mediated bacteriome depletion in Apc
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Anti-Bacterial Agents; Colon; Disease Models, Animal; Disease Progression; Gastrointestinal Microbiome; Goblet Cells; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neomycin; Streptomycin; Vancomycin | 2018 |
Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis.
Topics: Animals; Anti-Bacterial Agents; Betamethasone; Biological Availability; Chitosan; Conjunctivitis; Disease Models, Animal; Drug Delivery Systems; Eye Infections; Glucocorticoids; Hydrogels; Neomycin; Poloxamer; Rabbits | 2019 |
Pulp response of rats submitted to bleaching and the use of different anti-inflammatory drugs.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Calcitonin Gene-Related Peptide; Dental Pulp; Disease Models, Animal; Drug Combinations; Humans; Hydrocortisone; Immunohistochemistry; Male; Neomycin; Polymyxin B; Pulpitis; Rats; Rats, Wistar; Substance P; Tooth Bleaching; Tooth Bleaching Agents | 2019 |
Heterotaxy-spectrum heart defects in Zic3 hypomorphic mice.
Topics: Animals; Atrial Natriuretic Factor; Base Sequence; Disease Models, Animal; DNA Primers; Gene Components; Gene Expression Profiling; Gene Targeting; Heart Defects, Congenital; Heterotaxy Syndrome; Homeodomain Proteins; Humans; Mice; Mice, Mutant Strains; Molecular Sequence Data; Myocardium; Natriuretic Peptide, C-Type; Neomycin; Protein Precursors; Sequence Analysis, DNA; Transcription Factors | 2013 |
Cochlear implantation for chronic electrical stimulation in the mouse.
Topics: Animals; Auditory Pathways; Auditory Threshold; Brain Stem; Cochlea; Cochlear Implantation; Cochlear Implants; Deafness; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Equipment Design; Hearing; Mice; Mice, Inbred C57BL; Neomycin; Stapes | 2013 |
Inhibition of H3K4me2 Demethylation Protects Auditory Hair Cells from Neomycin-Induced Apoptosis.
Topics: Aminoglycosides; Animals; Apoptosis; Benzamidines; Caspase 3; Cyclopropanes; Cytoprotection; Disease Models, Animal; Hair Cells, Auditory; Histone Demethylases; Histones; Lysine; Methylation; Mice, Inbred C57BL; Neomycin; Organ of Corti; Phenyl Ethers; Piperazines | 2015 |
Roles of Toll-Like Receptor 4, IκB Kinase, and the Proteasome in the Intestinal Alterations Caused by Sepsis.
Topics: Acetylcholine; Animals; Cell-Penetrating Peptides; Cytokines; Dinoprostone; Disease Models, Animal; Duodenum; Endotoxins; Gastrointestinal Motility; Gene Expression Regulation; I-kappa B Kinase; Inflammation Mediators; Leupeptins; Male; Muscle Contraction; Neomycin; Polymyxin B; Potassium Chloride; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Kinase Inhibitors; Rabbits; Sepsis; Signal Transduction; Substance P; Toll-Like Receptor 4 | 2015 |
Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model.
Topics: Ampicillin; Animals; CD8-Positive T-Lymphocytes; Cell Proliferation; Cisplatin; Disease Models, Animal; Humans; Inflammation; Lactobacillus; Lung Neoplasms; Mice; Microbiota; Neomycin; Neoplasm Proteins; Probiotics; Vancomycin | 2015 |
Induction of single-sided deafness in the newborn rat and its consequence for cochlear nucleus volume development.
Topics: Acoustic Stimulation; Age Factors; Animals; Animals, Newborn; Auditory Threshold; Cochlear Nucleus; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Hearing; Hearing Loss, Unilateral; Male; Neomycin; Organ Size; Rats, Wistar | 2016 |
Sodium Selenite Acts as an Otoprotectant against Neomycin-Induced Hair Cell Damage in a Zebrafish Model.
Topics: Animals; Apoptosis; Biological Assay; Cell Count; Disease Models, Animal; Hair Cells, Auditory; In Situ Nick-End Labeling; Lateral Line System; Microscopy, Fluorescence; Neomycin; Neurons; Protective Agents; Sodium Selenite; Zebrafish | 2016 |
Structural changes in the inner ear over time studied in the experimentally deafened guinea pig.
Topics: Acoustic Stimulation; Animals; Cell Nucleus; Deafness; Disease Models, Animal; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Female; Glial Cell Line-Derived Neurotrophic Factor; Guinea Pigs; Male; Neomycin; Protein Synthesis Inhibitors; Sensory Receptor Cells; Spiral Ganglion; Time Factors | 2017 |
Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Ampicillin; Anastomosis, Surgical; Animals; Anti-Bacterial Agents; Barrett Esophagus; Disease Models, Animal; DNA, Bacterial; DNA, Ribosomal; Esophageal Neoplasms; Esophagus; Gastroesophageal Reflux; Jejunum; Male; Metronidazole; Microbiota; Neomycin; Penicillin G; Polymorphism, Restriction Fragment Length; Random Allocation; Rats; Rats, Wistar; Streptomycin; Vancomycin | 2016 |
Topography of auditory nerve projections to the cochlear nucleus in cats after neonatal deafness and electrical stimulation by a cochlear implant.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Cats; Cell Surface Extensions; Cochlear Implants; Cochlear Nerve; Cochlear Nucleus; Deafness; Disease Models, Animal; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Neomycin; Spiral Ganglion | 2008 |
Effects of age at onset of deafness and electrical stimulation on the developing cochlear nucleus in cats.
Topics: Age Factors; Age of Onset; Animals; Animals, Newborn; Cats; Child; Cochlear Implants; Cochlear Nucleus; Deafness; Disease Models, Animal; Electric Stimulation; Evoked Potentials, Auditory, Brain Stem; Humans; Neomycin | 2008 |
Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.
Topics: Adult Stem Cells; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical Warfare Agents; Corneal Diseases; Corneal Edema; Corneal Neovascularization; Corneal Opacity; Dexamethasone; Disease Models, Animal; Doxycycline; Drug Combinations; Enzyme Inhibitors; Female; Instillation, Drug; Limbus Corneae; Matrix Metalloproteinase Inhibitors; Mustard Gas; Neomycin; Rabbits | 2009 |
Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Translocation; Body Weight; Cells, Cultured; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Eating; Feces; Flagellin; Glutamine; Immunoglobulin A, Secretory; Intestines; Lymph Nodes; Male; Membrane Proteins; Metronidazole; Neomycin; Occludin; Phosphoproteins; Plasma Cells; Polymyxin B; Rats; Rats, Sprague-Dawley; Short Bowel Syndrome; Tight Junctions; Time Factors; Zonula Occludens-1 Protein | 2009 |
Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Hearing Loss; Kanamycin; Male; Mice; Mice, Inbred C57BL; Mortality; Neomycin | 2010 |
Synaptic plasticity after chemical deafening and electrical stimulation of the auditory nerve in cats.
Topics: Animals; Anti-Bacterial Agents; Cats; Cochlear Nerve; Cochlear Nucleus; Deafness; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Evoked Potentials, Auditory, Brain Stem; Female; Male; Microscopy, Electron; Neomycin; Nerve Endings; Neuronal Plasticity; Synapses | 2010 |
Antidepressant phenotype by inhibiting the phospholipase Cβ(1)--protein kinase Cγ pathway in the forced swim test.
Topics: Animals; Antidepressive Agents; Benzophenanthridines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Gene Knockdown Techniques; Male; Mice; Motor Activity; Naphthalenes; Neomycin; Oligonucleotides, Antisense; Phenotype; Phospholipase C beta; Protein Kinase C; Psychomotor Performance; Pyrrolidinones; Signal Transduction; Swimming | 2011 |
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
Topics: Animals; Anti-Bacterial Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; HEK293 Cells; Humans; Immunity, Innate; Inflammation Mediators; Keratin-19; Leukocyte Common Antigens; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Mice, Knockout; Neomycin; NF-kappa B; Phosphorylation; Polymyxin B; src-Family Kinases; Time Factors; Toll-Like Receptor 4; Transfection; Ursodeoxycholic Acid | 2011 |
Wound healing efficacy of Jatyadi Taila: in vivo evaluation in rat using excision wound model.
Topics: Administration, Topical; Amines; Animals; Bacitracin; Benzopyrans; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Female; Granulation Tissue; Hydroxyproline; Male; Medicine, Ayurvedic; Neomycin; Pentacyclic Triterpenes; Phytotherapy; Plant Extracts; Polymyxin B; Proteins; Rabbits; Rats; Rats, Wistar; Sitosterols; Skin; Wound Healing; Wounds and Injuries | 2011 |
Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo.
Topics: Amino Acid Sequence; Animals; Animals, Newborn; Cell Movement; Cell Survival; Cells, Cultured; Central Nervous System; Cerebral Ventricles; Chromatography, High Pressure Liquid; Cloning, Molecular; Culture Media, Conditioned; Deafness; Disease Models, Animal; Dose-Response Relationship, Drug; Doublecortin Domain Proteins; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Guinea Pigs; Humans; In Vitro Techniques; Male; Mice; Microscopy, Electron, Scanning; Microtubule-Associated Proteins; Neomycin; Nerve Growth Factors; Nerve Tissue Proteins; Neural Stem Cells; Neurites; Neurons; Neuropeptides; Rats; Spiral Ganglion; Tandem Mass Spectrometry; Transfection | 2012 |
Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Bacitracin; Chlorhexidine; Cornea; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Histocytochemistry; Male; Neomycin; Polymyxin B; Rats; Rats, Wistar; Treatment Outcome | 2012 |
Type I hair cell regeneration induced by Math1 gene transfer following neomycin ototoxicity in rat vestibular sensory epithelium.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Disease Models, Animal; Female; Gene Transfer Techniques; Genetic Therapy; Hair Cells, Vestibular; Hearing Loss, Sensorineural; Immunohistochemistry; Microscopy, Confocal; Microscopy, Electron, Scanning Transmission; Mitosis; Neomycin; Rats; Rats, Wistar; Regeneration | 2012 |
Inhibition of rat glioma growth by neomycin. Preliminary report.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Glioma; Magnetic Resonance Imaging; Neomycin; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tumor Cells, Cultured | 2002 |
An investigation into the wound-healing properties of essential oil of Ocimum gratissimum linn.
Topics: Administration, Cutaneous; Animals; Bacitracin; Cysteine; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Glycine; Inflammation; Medicine, African Traditional; Neomycin; Nigeria; Oils, Volatile; Ointments; Phytotherapy; Plant Oils; Rabbits; Random Allocation; Threonine; Wound Healing; Wounds and Injuries | 2003 |
Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heart Rate; Injections, Intraperitoneal; Injections, Intravenous; Lithium Carbonate; Lypressin; Mice; Motor Activity; Neomycin; Phospholipids; Piperidines; Polyuria; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Sphingosine | 2004 |
A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo.
Topics: Alleles; Animals; Disease Models, Animal; Kidney; Liver; Mice; Mice, Mutant Strains; Mutagenesis, Insertional; Neomycin; Polycystic Kidney, Autosomal Dominant; Proteins; TRPP Cation Channels | 2004 |
Perivascular delivery of neomycin inhibits the activation of NF-kappaB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injury.
Topics: Animals; Arteries; Catheterization; Constriction, Pathologic; Disease Models, Animal; Drug Delivery Systems; Female; Hyperplasia; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Neomycin; NF-kappa B; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley | 2004 |
Acoustic-electric interactions in the guinea pig auditory nerve: simultaneous and forward masking of the electrically evoked compound action potential.
Topics: Acoustic Stimulation; Adaptation, Physiological; Animals; Auditory Perception; Cochlear Nerve; Deafness; Disease Models, Animal; Electric Stimulation; Evoked Potentials, Auditory; Furosemide; Guinea Pigs; Models, Neurological; Neomycin; Perceptual Masking; Refractory Period, Electrophysiological; Time Factors | 2007 |
Effect of dietary fiber in edible seaweeds on the development of D-galactosamine-induced hepatopathy in rats.
Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Body Weight; Cecum; Chemical and Drug Induced Liver Injury; Dietary Fiber; Disease Models, Animal; Galactosamine; Intestines; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Neomycin; Rats; Rats, Wistar; Seaweed | 2007 |
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Disease Models, Animal; Eating; Endotoxins; Fatty Liver; Fructose; I-kappa B Proteins; Lipid Metabolism; Lipid Peroxidation; Lipogenesis; Liver; Mice; Mice, Inbred C57BL; Neomycin; NF-KappaB Inhibitor alpha; Polymyxin B | 2008 |
Response of the flat cochlear epithelium to forced expression of Atoh1.
Topics: Adenoviridae; Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Shape; Cell Transdifferentiation; Cochlea; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Unilateral; Labyrinth Supporting Cells; Neomycin; Regeneration; Time Factors; Transduction, Genetic | 2008 |
Bacterial endotoxins and liver haemorrhage in the oestrogenised chicken.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chickens; Disease Models, Animal; Endotoxins; Escherichia coli; Estradiol; Fatty Liver; Female; Hemorrhage; Liver Diseases; Male; Neomycin | 1980 |
Deaf animal models for studies of a multichannel cochlear prosthesis.
Topics: Animals; Basilar Membrane; Cats; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory; Hearing Disorders; Neomycin; Organ of Corti; Perilymph | 1982 |
Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Disease Models, Animal; Drug Therapy, Combination; Gentamicins; Keratitis; Neomycin; Polymyxin B; Prednisolone; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1980 |
Evoked potentials from the auditory nerve following sinusoidal electrical stimulation of the cochlea: new possibilities for preoperative testing in cochlear-implant candidates?
Topics: Acoustic Stimulation; Action Potentials; Animals; Artifacts; Cats; Cochlea; Cochlear Implants; Deafness; Disease Models, Animal; Electric Stimulation; Ethacrynic Acid; Evoked Potentials, Auditory, Brain Stem; Humans; Kanamycin; Neomycin; Vestibulocochlear Nerve | 1994 |
The role of systemic antibodies against intestinal Escherichia coli in the prevention of bacterial translocation of Escherichia coli in a burn model in mice.
Topics: Animals; Antibodies, Bacterial; Burns; Disease Models, Animal; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Immunoglobulin G; Intestines; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Neomycin | 1994 |
Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
Topics: Ammonia; Animals; Behavior, Animal; Blood Urea Nitrogen; Disease Models, Animal; Hepatic Encephalopathy; Male; Motor Activity; Neomycin; Portacaval Shunt, Surgical; Random Allocation; Rats; Rats, Sprague-Dawley | 1994 |
Laparoscopic-assisted full-thickness endoscopic polypectomy.
Topics: Animals; Cefotetan; Colonic Polyps; Colonoscopes; Colonoscopy; Disease Models, Animal; Electrocoagulation; Erythromycin; Humans; Laparoscopy; Neomycin; Pneumoperitoneum, Artificial; Polyethylene Glycols; Swine; Therapeutic Irrigation | 1993 |
Deafness induced cell size changes in rostral AVCN of the guinea pig.
Topics: Analysis of Variance; Animals; Cell Size; Cochlea; Cochlear Nucleus; Deafness; Disease Models, Animal; Guinea Pigs; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Neomycin | 1995 |
Cochlear implant-related osteoneogenesis in an animal model: fluorescent labeling.
Topics: Animals; Anti-Bacterial Agents; Calcinosis; Chinchilla; Cochlea; Cochlear Diseases; Cochlear Implants; Disease Models, Animal; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Neomycin; Photomicrography | 1994 |
Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Cochlea; Cochlear Implants; Dendrites; Disease Models, Animal; Guinea Pigs; Male; Neomycin; Nerve Degeneration; Nerve Growth Factors; Perfusion; Vestibulocochlear Nerve | 1995 |
An extended study: protective effects of nerve growth factor in neomycin-induced auditory neural degeneration.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Guinea Pigs; Hearing Loss, Sensorineural; Male; Neomycin; Nerve Degeneration; Nerve Growth Factors; Perfusion; Spiral Ganglion; Vestibulocochlear Nerve | 1995 |
Bacterial translocation in D-galactosamine-treated rats in a burn model.
Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bacterial Translocation; Burns; Colony Count, Microbial; Cytokines; Disease Models, Animal; Escherichia coli; Galactosamine; Lipopolysaccharides; Male; Neomycin; Rats; Rats, Wistar; Specific Pathogen-Free Organisms; Tissue Distribution; Wound Infection | 1996 |
Cochlear pathology induced by aminoglycoside ototoxicity during postnatal maturation in cats.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Cats; Cochlea; Deafness; Disease Models, Animal; Evoked Potentials, Auditory; Hair Cells, Auditory; Microscopy, Electron, Scanning; Neomycin; Nerve Degeneration; Spiral Ganglion | 1997 |
[Isolation and biological characterization of Legionella pneumophila mutants resistant to aminoglycoside antibotics and their protective action].
Topics: Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Chick Embryo; Disease Models, Animal; Drug Resistance, Microbial; Guinea Pigs; Legionella pneumophila; Legionnaires' Disease; Mutation; Neomycin; Streptomycin | 1997 |
Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Hair Cells, Auditory, Inner; Herpesvirus 1, Human; Mice; Mice, Inbred CBA; Neomycin; Nerve Degeneration; Nerve Growth Factors; Neurotrophin 3; Spiral Ganglion; Transfection; Wounds and Injuries | 1998 |
Treatment of chronic suppurative otitis media with topical ciprofloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Combinations; Humans; Hydrocortisone; Macaca fascicularis; Neomycin; Otitis Media, Suppurative; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome | 1998 |
Lactulose and neomycin attenuate leukocyte-endothelial cell adhesion in an animal model of inflammatory bowel disease.
Topics: Animals; Anti-Bacterial Agents; Cell Adhesion; Cell Communication; Disease Models, Animal; Endothelium; Gastrointestinal Agents; Ileitis; Ileum; Indomethacin; Inflammation; Inflammatory Bowel Diseases; Lactulose; Leukocytes; Male; Microcirculation; Neomycin; Rats; Rats, Sprague-Dawley | 1998 |
Development of a new, simple rat model of early alcohol-induced liver injury based on sensitization of Kupffer cells.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Calcium; Dietary Fats; Disease Models, Animal; Drug Therapy, Combination; Ethanol; Female; Inflammation; Kupffer Cells; Lipopolysaccharides; Liver; Liver Diseases, Alcoholic; Metabolic Clearance Rate; Necrosis; Neomycin; Polymyxin B; Rats; Rats, Wistar; Time Factors; Triglycerides; Tumor Necrosis Factor-alpha | 1999 |
Development of a competitive PCR method for in vitro and in vivo quantification of herpes simplex virus thymidine kinase and neomycin resistance-expressing cells used in a clinical trial.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; DNA, Recombinant; Drug Resistance, Microbial; Genetic Therapy; Graft vs Host Disease; Humans; Mice; Neomycin; Polymerase Chain Reaction; Reference Standards; Sensitivity and Specificity; Simplexvirus; Spleen; T-Lymphocytes; Thymidine Kinase; Transfection; Transplantation, Homologous; Transplantation, Isogeneic | 2000 |
Rumpshaker-like proteolipid protein (PLP) ratio in a mouse model with unperturbed structural and functional integrity of the myelin sheath and axons in the central nervous system.
Topics: Alternative Splicing; Animals; Axons; Central Nervous System; Disease Models, Animal; Gene Expression Regulation, Developmental; Gene Targeting; Introns; Mice; Mice, Knockout; Mice, Neurologic Mutants; Myelin Proteolipid Protein; Myelin Sheath; Neomycin; Nerve Tissue Proteins; Phenotype; RNA, Messenger; Stem Cells; Transcription, Genetic | 2001 |
Antinociceptive potency of aminoglycoside antibiotics and magnesium chloride: a comparative study on models of phasic and incisional pain in rats.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gentamicins; Injections, Spinal; Magnesium Chloride; Male; Neomycin; Pain; Pain Measurement; Rats; Rats, Wistar; Streptomycin | 2002 |
Quantitation of bacterial infection and antibiotic effect in the cornea.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Keratitis; Neomycin; Polymyxins; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1976 |
Topical antibiotic therapy of staphylococcal keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Chlortetracycline; Disease Models, Animal; Erythromycin; Gentamicins; Humans; In Vitro Techniques; Keratitis; Neomycin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 1977 |
Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells.
Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Southern; Cells, Cultured; Codon; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; DNA; Drug Resistance, Microbial; Embryo, Mammalian; Exons; Genetic Techniques; Kanamycin Kinase; Membrane Proteins; Mice; Molecular Sequence Data; Neomycin; Oligodeoxyribonucleotides; Phosphotransferases; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Restriction Mapping; Simplexvirus; Stem Cells; Thymidine Kinase | 1991 |
Toxicity of ototopical drugs: animal modeling.
Topics: Acetates; Acetic Acid; Action Potentials; Administration, Topical; Animals; Benzethonium; Chinchilla; Colistin; Disease Models, Animal; Drug Combinations; Hearing Loss, Sensorineural; Hydrocortisone; Neomycin; Otitis Media; Polymyxin B; Propylene Glycols | 1990 |
Evaluation of the effect of ototopical neomycin on spiral ganglion cell density in the guinea pig.
Topics: Animals; Cell Count; Cochlea; Deafness; Disease Models, Animal; Ear, Middle; Guinea Pigs; Neomycin; Spiral Ganglion; Time Factors | 1989 |
Development of neomycin-resistant WEHI-3B D+ murine cells as an in vivo model of acute nonlymphocytic leukemia.
Topics: Animals; Blotting, Southern; Cell Differentiation; Cell Line; Clone Cells; Disease Models, Animal; Drug Resistance; Female; Gentamicins; Leukemia, Myeloid, Acute; Mice; Mice, Inbred BALB C; Neomycin; Neoplasm Transplantation; Phenotype; Transfection | 1989 |
[Animal experiments with Campylobacter coli using suckling pigs].
Topics: Animals; Animals, Suckling; Campylobacter Infections; Disease Models, Animal; Erythromycin; Neomycin; Swine; Swine Diseases | 1988 |
[Comparative studies on the effect of antibacterial substances on inflammation and wound healing in rats].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Carrageenan; Dactinomycin; Disease Models, Animal; Edema; Folic Acid Antagonists; Granulation Tissue; Leucomycins; Neomycin; Pyrimidines; Rats; Trimethoprim; Wound Healing | 1972 |
Experimental corneal wound strength. 7-0 Silk vs 10-0 monofilament nylon.
Topics: Animals; Anterior Chamber; Atropine; Cornea; Disease Models, Animal; Gramicidin; Inflammation; Male; Methods; Neomycin; Nylons; Phenylephrine; Polymyxins; Postoperative Care; Postoperative Complications; Rabbits; Suture Techniques; Sutures; Textiles; Wound Healing | 1974 |
Experimental corneal wound strength.
Topics: Administration, Topical; Animals; Atropine; Cornea; Corneal Injuries; Dexamethasone; Disease Models, Animal; Gramicidin; Male; Neomycin; Parasympatholytics; Phenylephrine; Polymyxins; Rabbits; Wound Healing | 1974 |
An experimental study of acute neonatal enterocolitis--the importance of breast milk.
Topics: Animals; Animals, Newborn; Breast Feeding; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Disease Models, Animal; Enterocolitis, Pseudomembranous; Female; gamma-Globulins; Humans; Hypoxia; Ileum; Immunity, Maternally-Acquired; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Intestines; Klebsiella Infections; Milk; Neomycin; Rats | 1974 |
Noise-and drug-induced hearing loss in monkeys.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Conditioning, Operant; Deafness; Disease Models, Animal; Haplorhini; Hearing Loss, Noise-Induced; Kanamycin; Macaca; Methods; Neomycin; Papio; Quinidine; Sodium Salicylate; Time Factors | 1973 |
Urease-inhibiting action of some drugs in vitro and in vivo.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Ascorbic Acid; Bacitracin; Chloramphenicol; Chlortetracycline; Demeclocycline; Depression, Chemical; Disease Models, Animal; Enzyme Repression; Erythromycin; Female; Hydroxamic Acids; In Vitro Techniques; Intestines; Kanamycin; Male; Neomycin; Niacinamide; Oxytetracycline; Penicillin G; Rats; Streptomycin; Sulfamethoxypyridazine; Sulfisoxazole; Sulfonamides; Tetracycline; Urease | 1970 |
Elimination of S. typhi from the organs of carrier mice by combined treatment with BCG and neomycin.
Topics: Animals; BCG Vaccine; Bile Ducts; Carrier State; Disease Models, Animal; Gallbladder; Injections, Subcutaneous; Liver; Lymph Nodes; Mice; Neomycin; Salmonella Infections; Salmonella Infections, Animal; Salmonella typhi; Spleen; Thymus Gland | 1971 |
Chemotherapy of mice experimentally infected with Shigella flexneri.
Topics: Administration, Oral; Ampicillin; Animals; Antibodies; Colistin; Disease Models, Animal; Dysentery, Bacillary; Feces; Hemagglutination Tests; Intestines; Kanamycin; Lymph Nodes; Male; Mesentery; Mice; Neomycin; Oxytetracycline; Shigella | 1970 |
[Transmission of extrachromosomal drug resistance in staphylococci present in animals and the effect of neomycin on this process].
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Extrachromosomal Inheritance; Genetics, Microbial; Kidney; Lysogeny; Methods; Mice; Neomycin; Staphylococcal Infections; Staphylococcus | 1970 |
Study of bactericidal and bacteriostatic antibiotics in experimentally diabetic and senescent mice, in cases of lethal staphylococcal infection.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Erythromycin; Immunosuppression Therapy; Male; Mice; Neomycin; Oxacillin; Staphylococcal Infections | 1971 |